AstraZeneca V. EC — The Advocate General’s Opinion

Law360, New York (May 31, 2012, 1:19 PM EDT) -- On May 15, 2012, the advocate general of the EU Court of Justice issued his opinion on the appeal of the General Court’s judgment in AstraZeneca v. European Commission.[1] The advocate general largely agreed with the reasoning and holdings of the General Court, and recommended that the Court of Justice reject all appeals, including AstraZeneca’s appeal challenging the General Court’s analysis of the definition of the relevant market and the findings that certain IP/regulatory strategies pursued by AstraZeneca related to its product Losec constituted an abuse...
To view the full article, register now.